Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inspire Veterinary Partners (IVPR) EBIT (2022 - 2025)

Historic EBIT for Inspire Veterinary Partners (IVPR) over the last 4 years, with Q3 2025 value amounting to -$2.0 million.

  • Inspire Veterinary Partners' EBIT rose 1199.23% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year increase of 1789.65%. This contributed to the annual value of -$9.0 million for FY2024, which is 2581.39% down from last year.
  • According to the latest figures from Q3 2025, Inspire Veterinary Partners' EBIT is -$2.0 million, which was up 1199.23% from -$2.6 million recorded in Q2 2025.
  • In the past 5 years, Inspire Veterinary Partners' EBIT ranged from a high of -$932965.0 in Q2 2023 and a low of -$2.9 million during Q1 2024
  • Moreover, its 4-year median value for EBIT was -$2.0 million (2025), whereas its average is -$1.9 million.
  • The largest annual percentage gain for Inspire Veterinary Partners' EBIT in the last 5 years was 3616.11% (2024), contrasted with its biggest fall of 18484.37% (2024).
  • Over the past 4 years, Inspire Veterinary Partners' EBIT (Quarter) stood at -$1.4 million in 2022, then tumbled by 77.89% to -$2.4 million in 2023, then soared by 36.16% to -$1.5 million in 2024, then decreased by 28.09% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, -$2.6 million for Q2 2025, and -$2.0 million during Q1 2025.